Drawing up the wrong amount from a multi-dose vial is a genuine risk with compounded medications that do not come in pre-measured delivery devices
Symptoms are typically dose-related and occur early in treatment, with many patients seeing improvement within a few weeks as the body adapts to slower gastric emptying and central effects
Moreover, due to its nauseating effect at higher doses (134136), PYY has not been pursued as an anti-obesity target
Additionally, GLP-1Ra treatment was linked to a metabolic shift toward lipid utilization, modulation of the immune response, and improved endothelial function, which may contribute to its favorable effect on CAD regression
However, a more recent analysis of clinical research shows that increased risk of fetal mortality seems to occur only in the studies where antenatal magnesium is used for tocolysis and not for fetal neuroprotection or pre-eclampsia/eclampsia